The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 25, 2022
Filed:
Jan. 08, 2019
Applicants:
The Hong Kong Polytechnic University, Hong Kong, CN;
The Chinese University of Hong Kong, Hong Kong, CN;
Assignees:
The Hong Kong Polytechnic University, Hong Kong, CN;
The Chinese University of Hong Kong, Hong Kong, CN;
Primary Examiner:
Int. Cl.
CPC ...
C07C 251/86 (2006.01); A61P 31/04 (2006.01); C07C 215/50 (2006.01); C07C 217/58 (2006.01); C07C 251/24 (2006.01); C07C 255/53 (2006.01); C07C 255/58 (2006.01); C07C 255/59 (2006.01); C07C 255/61 (2006.01); C07C 311/39 (2006.01); C07C 311/44 (2006.01); C07D 257/04 (2006.01); C07D 231/20 (2006.01); C07D 231/42 (2006.01); C07D 249/12 (2006.01); C07D 307/90 (2006.01); C07D 403/12 (2006.01);
U.S. Cl.
CPC ...
C07C 251/86 (2013.01); A61P 31/04 (2018.01); C07C 215/50 (2013.01); C07C 217/58 (2013.01); C07C 251/24 (2013.01); C07C 255/53 (2013.01); C07C 255/58 (2013.01); C07C 255/59 (2013.01); C07C 255/61 (2013.01); C07C 311/39 (2013.01); C07C 311/44 (2013.01); C07D 231/20 (2013.01); C07D 231/42 (2013.01); C07D 249/12 (2013.01); C07D 257/04 (2013.01); C07D 307/90 (2013.01); C07D 403/12 (2013.01);
Abstract
This invention relates to compounds of formula 1, 2 or 3 a pharmaceutically acceptable salt, or solvate thereof, wherein X, Y, R, R, R, R, and Rare as defined herein. The compounds are antimicrobial agents that may be used to treat various bacterial and protozoal infections and disorders related to such infections. The invention also relates to pharmaceutical compositions containing the compounds and to methods of treating bacterial and protozoal infections by administering the compounds of formula 1, 2 or 3.